Gene therapy that targets retinal ganglion cells with light-sensitive cone opsins helps restore vision in mice. Researchers report a potential human treatment could be available within three years.
A team of University of California, Berkeley, scientists in collaboration with researchers at the University of Munich and University of Washington, in Seattle, has discovered a chemical that temporarily restores some vision to blind mice, and is working on an improved compound that may someday allow people with degenerative blindness to see again.
Antabuse, a drug commonly prescribed to treat alcohol use disorder, may help to restore eyesight in people with genetic retinitis pigmentosa and other disorders associated with retinal degeneration.
A British woman is able to read the time clearly for the first time in years after receiving a new bionic eye implant.
Researchers have developed a new type of nanowire material that may improve both retinal and brain implants.
New retinal implants could restore vision up to five times better than current technology, a new study reports.
Foundation Fighting Blindness and Mass. Eye and Ear Host June 1 Optogenetics Workshop to Fast-Track Innovative Approaches to Save and...